1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D1830487EA64ED0A00258D400056B7D6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew!SearchView&Query=(Field ph=T and FIELD+publishdate+>=+11/02/2003)+AND+(the)+and+(field+ItemCatalog=DB)&SearchWV=1&SearchFuzzy=0&SearchOrder=1&Start=1&Count=10
18
19SearchView&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%2011/02/2003)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=0&SearchOrder=1&Start=1&Count=10
2018.97.9.175
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Search Results

Results 1 - 10 of 797 Total Hits, .

    |    

DB Image

Cariprazine: The Market Landscape for a Second-Generation Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW This short case study examines cariprazine, a second-generation atypical antipsychotic therapy developed by Forest Laboratories and Gedeon Richter... (ID 5302)
Companies Profiled: Forest Laboratories, Gedeon Richter Ltd.

$200.00

DB Image

Key Factors in Conducting Successful Co-PromotionsDirect access to this research is not included with your membership level.This is a pharma specific study.

Study Overview The ability of two companies to integrate themselves into a working alliance ultimately drives the success of a co-promotion effort... (ID 4683)
Companies Profiled: Abbott, Sanofi-aventis, Daiichi Pharmaceutical Co., AstraZeneca, more ...

$430.95

DB Image

Key Factors in Successful Global Pharmaceutical LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Integrated global marketing launch systems generate rapid sales uptake and help produce blockbuster products that realize their maximum economic potential in the global marketplace... (ID 4564)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...

$274.95

DB Image

Resources Required to Manage Winning Commercial Operations in U.S. Pharmaceutical FinanceDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.

Non-members: Click here to sign-up for a complimentary tour of "Resources Required to Manage Winning Commercial Operations in U... (ID 4911)
Companies Profiled: Roche, Biogen Idec, GlaxoSmithKline, Sigma-Tau, more ...

$1415.00

DB Image

Global Trends in E-detailingDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

Study Overview Based on a survey of nine pharmaceutical organizations, this 17-slide presentation measures the type and prevalence of e-detailing act... (ID 4574)
Companies Profiled: AstraZeneca, Axcan Pharma, Janssen Cilag Pharmaceutical, Datapharm, more ...

$299.95

DB Image

Library Services Staffing MetricsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Library Services Staffing Metrics" STUDY OVERVIEW Company libraries provide valuabl... (ID 5329)
Companies Profiled: Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, Eisai, Eli Lilly, more ...

DB Image

Zyprexa: Portrait of a Successful Lifecycle for an Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

STUDY OVERVIEW This 4-page case study examines Zyprexa, the third atypical antipsychotic therapy when it was approved in 1996 by the FDA... (ID 5303)
Companies Profiled: Eli Lilly

$200.00

DB Image

Meeting the Needs of Payers Through the Market Access Function: Structure, Impact, and ActivitiesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Meeting the Needs of Payers Through the Market Access Function: Structure, Impact, an... (ID 5789)
Companies Profiled: AbbVie, Alkermes, Bayer, Boehringer Ingelheim, more ...

DB Image

Optimizing the Managed Markets Function: Compensation, Clinical Specialists and Staffing LevelsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Optimizing the Managed Markets Function: Compensation, Clinical Specialists and Staff... (ID 5338)
Companies Profiled: United Therapeutics, Horizon Pharma, actavis, Purdue Pharma, more ...

DB Image

Optimizing Managed Care Group ResourcesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

To ensure organizational health and competitiveness, pharmaceutical and biotechnology leaders must continually identify optimal resource levels... (ID 4915)
Companies Profiled: Genentech, Roche, NovoNordisk, GlaxoSmithKline, more ...

$2115.00